
Hansa Biopharma
HNSA | XSTO
Overview
Corporate Details
- ISIN(s):
- SE0002148817 (+1 more)
- LEI:
- 549300LLEO25ZJJ3NT91
- Country:
- Sweden
- Address:
- Box 785, 220 07 Lund
- Website:
- https://www.hansabiopharma.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Hansa Biopharma is an innovative and rapidly growing biopharmaceutical company. Our vision is a world where all patients with rare immunologic diseases can lead long and healthy lives. But we often see that people with rare diseases are relegated to the impossible and left to fend for themselves. That’s not the way forward. We see all patients as equal individuals with individual needs. A point of view that gives us a unique ability to deliver the most inclusive care to everyone. For us the mission is clear – we want to develop lifesaving and life altering therapies to those who need them the most. And ultimately, we can – and will – eliminate rare diseases, one patient at a time. So how do we aim to achieve our goal? • We partner with global scientific, medical, and patient communities to identify the most urgent needs • We work relentlessly to meet the needs and create lifesaving treatments • Our lead program enables kidney transplantation in difficult-to-transplant patients
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2025-05-26 18:40 |
Regulatory News Service
Hansa Biopharma plans restructuring to optimize resource allocation and improve…
|
English | 220.5 KB | |
2025-05-26 18:40 |
Regulatory News Service
Hansa Biopharma planerar omstrukturering för att optimera resursfördelning och …
|
Swedish | 204.8 KB | |
2025-05-26 07:00 |
Proxy Solicitation & Information Statements
Notice to Annual General Meeting in Hansa Biopharma AB (publ)
|
English | 206.6 KB | |
2025-05-26 07:00 |
General Meeting Notice
Kallelse till årsstämma i Hansa Biopharma AB (publ)
|
Swedish | 461.9 KB | |
2025-04-24 08:00 |
Interim Report
|
Swedish | 1.8 MB | |
2025-04-24 08:00 |
Interim Report
|
English | 1.6 MB | |
2025-04-24 07:00 |
Board/Management Change
Hansa Biopharma appoints new Chief Executive Officer
|
English | 178.1 KB | |
2025-04-24 07:00 |
Board/Management Change
Hansa Biopharma utser ny VD
|
Swedish | 185.4 KB | |
2025-03-21 15:01 |
Annual Report
|
Swedish | 2.2 MB | |
2025-03-21 15:01 |
Annual Report
|
English | 2.2 MB | |
2025-02-06 07:00 |
Annual Report
|
Swedish | 1.6 MB | |
2025-02-06 07:00 |
Annual Report
|
English | 1.4 MB | |
2024-12-17 21:40 |
Earnings Release
Hansa Biopharma announces positive full results from 15-HMedIdeS-09 Phase 2 stu…
|
English | 162.0 KB | |
2024-12-17 21:40 |
Earnings Release
Hansa Biopharma meddelar positiva fullständiga resultat från fas 2-studien 15-H…
|
Swedish | 222.7 KB | |
2024-10-17 07:00 |
Earnings Release
|
Swedish | 1.6 MB |
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
2024-06-17 | Anne Säfström Lanner | Other | Sell | 10,487 | 443,285.49 SEK |
2024-06-17 | Sören Tulstrup | Other | Sell | 9,199 | 388,841.73 SEK |
2024-06-17 | Sören Tulstrup | Other | Buy | 35,200 | N/A |
2022-07-19 | Peter Nicklin | Other | Buy | 14,500 | 1,032,192.68 SEK |
2022-06-17 | Christian Kjellman | Other | Buy | 6,915 | 345,680.85 SEK |
2022-06-17 | Donato Spota | Other | Sell | 4,638 | 231,853.62 SEK |
2022-06-17 | Christian Kjellman | Other | Sell | 4,002 | 200,059.98 SEK |
2022-06-17 | Sören Tulstrup | Other | Sell | 3,925 | 196,210.75 SEK |
2022-06-17 | Sören Tulstrup | Other | Buy | 3,925 | 196,210.75 SEK |
2022-06-17 | Anne Säfström Lanner | Other | Sell | 2,685 | 134,223.15 SEK |
Peer Companies
Company | Country | Ticker | View | |
---|---|---|---|---|
![]() |
ANIMALCARE GROUP PLC | United Kingdom | ANCR | |
![]() |
Annexin Pharmaceuticals AB | Sweden | ANNX | |
|
Apontis Pharma AG | Germany | APPH | |
![]() |
Aptahem AB | Sweden | APTA | |
![]() |
Arctic Bioscience | Norway | ABS | |
![]() |
ArcticZymes Technologies | Norway | AZT | |
|
argenx SE | Netherlands (Kingdom of the) | 1AE | |
![]() |
ARIX BIOSCIENCE PLC | United Kingdom | ARIX | |
![]() |
AroCell AB | Sweden | AROC | |
![]() |
Arterra Bioscience | Italy | ABS |